Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A de Jonge

Showing results (151-160 of 286) with videos related to

Pageof 29
Sort By:
Viruses|November 27, 2019
Evolution of BACON Domain Tandem Repeats in crAssphage and Novel Gut Bacteriophage LineagesPatrick A de Jonge, F A Bastiaan von Meijenfeldt, Laura E van Rooijen, et al.
Essays in Biochemistry|November 29, 2024
Characteristics of phage-plasmids and their impact on microbial communitiesRuweyda Sayid, Anne W M van den Hurk, Daniela Rothschild-Rodriguez, et al.
European Journal of Pharmacology|June 19, 1985
Differential selectivities of RU 24969 and 8-OH-DPAT for the purported 5-HT1A and 5-HT1B binding sites. Correlation between 5-HT1A affinity and hypotensive activityH N Doods, H O Kalkman, A De Jonge, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2003
Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validationD Moneta, C Geroni, O Valota, et al.
Anti-Cancer Drugs|December 1, 2012
Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairmentCarla M L van Herpen, Ulrik Lassen, Ingrid M E Desar, et al.
Journal of Neurology|August 18, 2004
Physiotherapy in Parkinson's disease: utilisation and patient satisfactionSamyra H J Keus, Bastiaan R Bloem, Dagmar Verbaan, et al.
Biochimica Et Biophysica Acta|May 10, 1979
Factors affecting the hydrolysis of ceramide-3 by alpha-galactosidase A from human liverA W Schram, M N Hamers, M R Samson, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development GroupC J A Punt, M J A de Jonge, S Monfardini, et al.
Journal of Autonomic Pharmacology|December 1, 1983
Selective stimulation of vascular postjunctional alpha-adrenoreceptors by (-)-amidephrine in rats and catsM J Mathy, H N Doods, M J Thoolen, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1986
Inhibitory effect of alpha-1 adrenoceptor stimulation on cardiac sympathetic neurotransmission in pithed normotensive ratsA de Jonge, G van den Berg, J Q Qian, et al.
Pageof 29

Showing results (151-160 of 286) with videos related to

Sort By:
Pageof 29
Viruses|November 27, 2019
Evolution of BACON Domain Tandem Repeats in crAssphage and Novel Gut Bacteriophage LineagesPatrick A de Jonge, F A Bastiaan von Meijenfeldt, Laura E van Rooijen, et al.
Essays in Biochemistry|November 29, 2024
Characteristics of phage-plasmids and their impact on microbial communitiesRuweyda Sayid, Anne W M van den Hurk, Daniela Rothschild-Rodriguez, et al.
European Journal of Pharmacology|June 19, 1985
Differential selectivities of RU 24969 and 8-OH-DPAT for the purported 5-HT1A and 5-HT1B binding sites. Correlation between 5-HT1A affinity and hypotensive activityH N Doods, H O Kalkman, A De Jonge, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2003
Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validationD Moneta, C Geroni, O Valota, et al.
Anti-Cancer Drugs|December 1, 2012
Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairmentCarla M L van Herpen, Ulrik Lassen, Ingrid M E Desar, et al.
Journal of Neurology|August 18, 2004
Physiotherapy in Parkinson's disease: utilisation and patient satisfactionSamyra H J Keus, Bastiaan R Bloem, Dagmar Verbaan, et al.
Biochimica Et Biophysica Acta|May 10, 1979
Factors affecting the hydrolysis of ceramide-3 by alpha-galactosidase A from human liverA W Schram, M N Hamers, M R Samson, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development GroupC J A Punt, M J A de Jonge, S Monfardini, et al.
Journal of Autonomic Pharmacology|December 1, 1983
Selective stimulation of vascular postjunctional alpha-adrenoreceptors by (-)-amidephrine in rats and catsM J Mathy, H N Doods, M J Thoolen, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1986
Inhibitory effect of alpha-1 adrenoceptor stimulation on cardiac sympathetic neurotransmission in pithed normotensive ratsA de Jonge, G van den Berg, J Q Qian, et al.
Pageof 29